List view / Grid view
27 July 2018 | By Bruker
Two webinar sessions will be available on 27 September at 9AM (BST) and 4PM (BST). Select your preferred time slot during registration. The webinar will describe how 2D NMR can offer protein biochemists unprecedented analytical precision. By assigning just one spectrum, users can obtain a unique fingerprint of a protein at…
12 June 2018 | By Thermo Fisher Scientific
Supports development of analytical workflows to generate precise molecular profiles of patients...
8 June 2018 | By Bruker
At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets...
8 June 2018 | By Thermo Fisher Scientific
Today, at the 66th Conference on Mass Spectrometry and Allied Topics, Thermo Scientific and Evosep announced a joint effort to develop and promote robust, high-throughput workflows for clinical proteomics...
9 May 2018 | By European Pharmaceutical Review
Researchers have developed a new biotech technique that promises to accelerate research into protein therapies...
18 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A group of researchers is showing how artificial intelligence approaches can help identify cause-effect relationships within data...
26 March 2018 | By European Pharmaceutical Review
Brazilian researchers combine mass spectrometry, 2-D liquid chromatography and ion mobility to identify over 10,000 proteins in brain cells possibly involved in schizophrenia.
4 January 2018 | By Johan Devenyns, Johan Devenyns - PharmaFluidics
Much rests on the further development of bioanalytical technologies which allow the highest level of sensitivity on small samples, and robust, high reproducibility across large populations. Johan Devenyns, CEO PharmaFluidics, explains further...
11 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
New study shows ALK inhibitor ceritinib may have the ability to be used for more than ALK-rearranged non-small cell lung cancer...
2 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A group of scientists have created a computer model to analyse amyloid beta accumulation using published papers and clinical studies...
23 December 2014 | By Axel Ducret, Biochemist
This article will focus on some of the critical aspects of transition biomarkers discovered in classical (MS-based) proteomics workflows and on the challenges to be met before validated assays can become more routine in the clinical laboratory...
5 September 2014 | By Marco Casteleijn & Dominique Richardson, University of Helsinki
Pharmaceutical biotechnology is big business; it currently consists of 1/6 of the total volume of the pharmaceutical market and continues to grow steadily. Expression of therapeutic proteins is mainly done in living cells, although ‘cell free protein synthesis’ (CFPS) or ‘in-vitro transcription translation’ (IVTT) is beginning to emerge as an…
Send this to a friend
Follow: